No­var­tis earns ad­com­m's vote of sup­port in come­back FDA re­view for En­tresto in sought-af­ter heart fail­ure pa­tients

No­var­tis’ En­tresto once seemed left for dead in its pur­suit of a set of holy-grail heart fail­ure pa­tients, but the FDA turned the tide af­ter …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.